I'm also interested in the high cost of these drugs.
I direct this to Ms. Little as well as Ms. Vowles.
Is there anything afoot to reduce the high cost of these drugs? As it goes forward, the drug has existed for a longer period and the company has had an opportunity for a return on its investment. Is there any evidence or thought that prices will go down or that there can be some relief to that?